Clinical Trial Update: Phase 1 and Phase 2 Clinical Trials of SNUBH-NM-333(18F) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1 and Phase 2 clinical trials of SNUBH-NM-333(18F) for Alzheimer's disease have been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• SNUBH-NM-333(18F)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Alzheimer Disease | Phase 1, Phase 2 | Status: TERMINATED